View Clinical Trial (Medical Research Study)
The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin - NCT00665613-10305(Clinical Trial 217383)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Staten Island |
|
State:
|
|
NY |
| Zip Code: |
|
10305 |
| Conditions: |
|
Osteoporosis |
| Purpose: |
|
The purpose of this study is to determine if osteoporosis is an unrecognized complication of
chronic anticoagulation with warfarin.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Patients on warfarin that have had BMD within a year
Exclusion Criteria:
- Patients on bisphosphates, SERMS, anticonvulsants, estrogens, androgens, calcitonin,
hctz and thyroid hormone replacement |
|
|
|
| Study is available at: |
|
Staten Island University Hospital
Staten Island, NY 10305
United States
Primary Contact:
Mario Castellanos, MD
Email: mcastellanos@siuh.edu
Phone: 718-226-9000
Secondary Contact:
Mario Castellanos, MD
Email: mcastellanos@siuh.edu
Phone: 7182269000 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|